Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

parkinson's disease

This page shows the latest parkinson's disease news and features for those working in and with pharma, biotech and healthcare.

Novo Nordisk Foundation commits €127m for new cell therapy facility

Novo Nordisk Foundation commits €127m for new cell therapy facility

This will help to accelerate treatments for people with diseases including chronic heart failure, Parkinson’s disease, kidney disease, type 1 diabetes and several forms of cancer. ... In the US alone, it’s been calculated that out of 58 million

Latest news

More from news
Approximately 66 fully matching, plus 203 partially matching documents found.

Latest Intelligence

  • Vive la différence: as Cannes celebrates life-changing creative, how did pharma do? Vive la différence: as Cannes celebrates life-changing creative, how did pharma do?

    It’s hard to believe that a decade ago, pharma wasn’t part of the Cannes conversation. ... Examples include:. ‘Scrolling Therapy’ (Grand Prix, Pharma) – an AI-powered tool that helps people with Parkinson’s disease control their social media

  • The power of the patient influencer The power of the patient influencer

    Matt Eagles, who was diagnosed with Parkinson’s disease at just seven years old, has taken an active role as an advocate in the Parkinson’s community. ... His work has helped him advocate for greater awareness and understanding of Parkinson’s

  • Parkinson’s disease: past, present and future Parkinson’s disease: past, present and future

    of dopamine in Parkinson’s disease treatment and the conceptualisation of new medicines. ... Their discoveries emboldened the scientific community to conduct human trials in patients with Parkinson’s disease.

  • Gene therapy, gene editing and perspectives on future use in Parkinson’s disease Gene therapy, gene editing and perspectives on future use in Parkinson’s disease

    The application of this technology is clear in monogenic diseases and its potential is now being investigated for idiopathic diseases without a known single genetic cause, such as Parkinson’s disease ... Gene editing describes the modification of a

  • A relentless commitment to neuroscience A relentless commitment to neuroscience

    It stops time and halts joy because of troublesome dyskinesia. This is Parkinson’s disease. ... The outlook can be sobering and, sadly, people living with chronic neurological illnesses including chronic migraine, Parkinson’s disease and psychiatric

More from intelligence
Approximately 0 fully matching, plus 36 partially matching documents found.

Latest appointments

  • Prevail Therapeutics adds to its board of directors Prevail Therapeutics adds to its board of directors

    The Prevail team has already made great progress in developing potential treatments for Parkinson’s disease and other neurodegenerative diseases, and I look forward to partnering with the team to help

  • Voyager Therapeutics appoints Matthew Ottmer as chief operating officer Voyager Therapeutics appoints Matthew Ottmer as chief operating officer

    He said: “I am thrilled to join Voyager at this important time during the company’s evolution. ... Developing and implementing the initial commercial strategy and planning for VY-AADC for Parkinson’s disease is a top priority, especially as we

  • Newron Pharma appoints commercial affairs VP Newron Pharma appoints commercial affairs VP

    He brings sales and marketing experience from Johnson &Johnson, and served as franchise marketing director for psychiatry, Parkinson's disease and migraine products at Novartis. ... future. “At the same time we welcome Dennis as a new member of

  • Voyager Therapeutics appoints chief financial officer Voyager Therapeutics appoints chief financial officer

    This strong foundation combined with the company's recent positive interim phase Ib data from its lead program VY-AADC01 for advanced Parkinson's disease and the opportunity to join a ... I am thrilled to join the Voyager team and meaningfully contribute

  • Pfizer appoints chief scientific officer Pfizer appoints chief scientific officer

    Having first joined Harvard in 1989, Dr Isacson's work in neurogenerative disorders, particularly for Parkinson's disease, has become internationally renowned with his laboratory now one of the leading academic ... s disease, where we are working to

More from appointments
Approximately 0 fully matching, plus 17 partially matching documents found.

Latest from PMHub

  • The ever-shifting landscape of health wearables The ever-shifting landscape of health wearables

    help supress the tremors caused by conditions like Parkinson’s disease.3. ... A whole host of health and fitness apps have now been developed to work in conjunction with wearable tech – running apps, mindfulness apps, ECG apps, blood pressure apps,

  • Robust Review: Vetting Evidence Generation Plan

    A client was interested in launching their product for an indication within Parkinson's disease.

  • September 2020: diversity and inclusion in clinical trials round-up September 2020: diversity and inclusion in clinical trials round-up

    Lack of awareness of clinical trials is a barrier faced by Hispanic people with Parkinson’s disease. ... A recent study looked into the barriers to participation in clinical trials faced by Hispanic people who have Parkinson’s disease.

  • Forging innovative solutions by merging art and science

    She studied neuroscience at the University of Toronto, worked in labs at Toronto’s Krembil Neuroscience Centre researching Parkinson’s disease and hippocampal neurogenesis, and was also a therapist in private ... practice. Ariel’s uncommon

  • The ALS patient journey

    Amyotrophic lateral sclerosis (ALS) is the most common form of motor neuron disease (MND). ... That will be the start of ALS, but your doctor will want to rule out other things, for example, Parkinson’s disease or multiple sclerosis.

More from PMHub
Approximately 0 fully matching, plus 10 partially matching documents found.

Subscribe to our email news alerts

PMHub

Add my company
The Creative Engagement Group

We create experiences that inspire lasting change. Exceptional experiences that engage people, change mindsets and behaviour, enrich cultures, increase skills...

Latest intelligence

The importance of accelerating clinical trial diversity
Diversity shouldn’t be an afterthought – it’s an investment in the credibility of scientific endeavour...
Digital Opinion Leaders: The Role of Influencers in Medical Communications
There are many informed, knowledgeable HCPs who talk about a disease state online, but not all of them are influencers. This paper explores who digital opinion leaders are and how...
Creating Hope Though Action – World Suicide Prevention Day
At Mednet Group, we believe that actions speak louder than words. That's why we're getting behind this year's Suicide Prevention Day campaign of 'creating hope through action'....

Quick links